Correlation Between Definitive Healthcare and Albireo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Definitive Healthcare and Albireo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Definitive Healthcare and Albireo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Definitive Healthcare Corp and Albireo Pharma, you can compare the effects of market volatilities on Definitive Healthcare and Albireo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Definitive Healthcare with a short position of Albireo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Definitive Healthcare and Albireo Pharma.

Diversification Opportunities for Definitive Healthcare and Albireo Pharma

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Definitive and Albireo is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Definitive Healthcare Corp and Albireo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albireo Pharma and Definitive Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Definitive Healthcare Corp are associated (or correlated) with Albireo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albireo Pharma has no effect on the direction of Definitive Healthcare i.e., Definitive Healthcare and Albireo Pharma go up and down completely randomly.

Pair Corralation between Definitive Healthcare and Albireo Pharma

Allowing for the 90-day total investment horizon Definitive Healthcare Corp is expected to under-perform the Albireo Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Definitive Healthcare Corp is 1.92 times less risky than Albireo Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Albireo Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,083  in Albireo Pharma on December 20, 2023 and sell it today you would earn a total of  1,332  from holding Albireo Pharma or generate 43.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy47.17%
ValuesDaily Returns

Definitive Healthcare Corp  vs.  Albireo Pharma

 Performance 
       Timeline  
Definitive Healthcare 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Definitive Healthcare Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in April 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Albireo Pharma 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Albireo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Albireo Pharma is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Definitive Healthcare and Albireo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Definitive Healthcare and Albireo Pharma

The main advantage of trading using opposite Definitive Healthcare and Albireo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Definitive Healthcare position performs unexpectedly, Albireo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will offset losses from the drop in Albireo Pharma's long position.
The idea behind Definitive Healthcare Corp and Albireo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments